Abstract:Objective To investigate the application of serum levels of interleukin-18(IL-18) and matrix metalloproteinase-9(MMP-9) detection in acute coronary symptoms.Methods The enzyme-linked immunosorbent assay(ELISA) determination of 150 patients with serum IL-18,MMP-9 levels.Results Serum IL-18,MMP-9 levels in 9 patients with acute coronary syndrome was significantly higher in the control group and stable angina pectoris difference between the two groups was statistically significant(P<0.05);Double support and three vascular disease in patients with serum IL-18,MMP-9 levels higher than those of the control group,the difference between groups was statistically significant(P<0.05).Conclusions ACS serum IL-18 and MMP-9 levels increased plaque stability is expected as a predictor of ACS.Serum IL-18,MMP-9 in patients with acute coronary syndrome has important clinical value.

Clinical significance of serum interleukin-18 (IL-18) and matrix metalloproteinase-(MMP-9) on acute coronary syndrome